litlas
Log inCreate account

W. Douglas Weaver

Active 1977–2025

Also published as
W.Douglas Weaver · W Douglas Weaver · W. DOUGLAS WEAVER
96
Papers
21,745
Citations
86
h-index
96
i10-index

Citations

Citations per year for W. Douglas Weaver1944: 1 citations1977: 1 citations1978: 1 citations1979: 7 citations1981: 1 citations1982: 4 citations1983: 2 citations1984: 6 citations1985: 1 citations1986: 8 citations1987: 1 citations1988: 11 citations1989: 10 citations1990: 34 citations1991: 28 citations1992: 20 citations1993: 43 citations1994: 49 citations1995: 69 citations1996: 99 citations1997: 129 citations1998: 170 citations1999: 133 citations2000: 192 citations2001: 182 citations2002: 145 citations2003: 205 citations2004: 199 citations2005: 198 citations2006: 173 citations2007: 152 citations2008: 120 citations2009: 113 citations2010: 157 citations2011: 122 citations2012: 108 citations2013: 118 citations2014: 108 citations2015: 111 citations2016: 101 citations2017: 87 citations2018: 84 citations2019: 227 citations2020: 250 citations2021: 200 citations2022: 133 citations2023: 96 citations2024: 148 citations2025: 87 citations2026: 6 citations1945–1976: no citations, so these years are not shown1980: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,979 citing papers, 33.4% of this breakdownUnited Kingdom: 493 citing papers, 8.3% of this breakdownCanada: 318 citing papers, 5.4% of this breakdownGermany: 284 citing papers, 4.8% of this breakdownItaly: 274 citing papers, 4.6% of this breakdownNetherlands: 222 citing papers, 3.7% of this breakdownFrance: 197 citing papers, 3.3% of this breakdownChina: 188 citing papers, 3.2% of this breakdownAustralia: 178 citing papers, 3% of this breakdownSpain: 157 citing papers, 2.7% of this breakdownSweden: 150 citing papers, 2.5% of this breakdownJapan: 116 citing papers, 2% of this breakdown
0%33.4%Other 23.1%

Institutions

Fields

  • Medicine82.3%
  • Biochemistry, Genetics and Molecular Biology6.2%
  • Immunology and Microbiology3.1%
  • Engineering1.8%
  • Economics, Econometrics and Finance1.4%
  • Health Professions1.4%
  • Other3.8%

Topics

  • Acute Myocardial Infarction Research11.9%
  • Cardiac Imaging and Diagnostics4.9%
  • Cardiac Arrest and Resuscitation4.8%
  • Coronary Interventions and Diagnostics4.4%
  • Heart Failure Treatment and Management2.9%
  • Antiplatelet Therapy and Cardiovascular Diseases2.7%
  • Other68.4%

Coauthors

All papers

Open in search
  1. Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome

    Authors: Michelle L. O’Donoghue, Eugene Braunwald, Harvey D. White, Dylan P. Steen, Mary Ann Lukas, Elizabeth Tarka, Philippe Gabríel Steg, Judith S. Hochman, Christoph Bode, Aldo P. Maggioni, KyungAh Im, Jennifer B. Shannon, Richard Y. Davies, Sabina A. Murphy, Sharon Crugnale, Stephen D. Wiviott, Marc P. Bonaca, David F. Watson, W. Douglas Weaver, Patrick W. Serruys, Christopher P. Cannon - JAMA 2014 cited by 456

  2. EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention

    Authors: C. Michael Gibson, Robert P. Giugliano, Robert A. Kloner, Christoph Bode, Michał Tendera, András Jánosi, Béla Merkely, Jacek Godlewski, Rim Halaby, Serge Korjian, Yazan Daaboul, Anjan Chakrabarti, Kathryn Spielman, Brandon J Neal, W. Douglas Weaver - European Heart Journal 2015 cited by 155

  3. Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

    Authors: Claes Held, Harvey D. White, Ralph Stewart, Andrzej Budaj, Christopher P. Cannon, Judith S. Hochman, Wolfgang Köenig, Agneta Siegbahn, Philippe Gabríel Steg, Joseph Soffer, W. Douglas Weaver, Ollie Östlund, Lars Wallentin, on behalf of the STABILITY Investigators - Journal of the American Heart Association 2017 cited by 281

  4. Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy

    Authors: Amel Karaa, Richard Haas, Amy Goldstein, Jerry Vockley, W. Douglas Weaver, Bruce H. Cohen - Neurology 2018 cited by 148

  5. Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

    Authors: Christopher B. Granger, Kenneth W. Mahaffey, W. Douglas Weaver, Pierre Théroux, Judith S. Hochman, Thomas G. Filloon, Scott A. Rollins, Thomas G. Todaro, José Carlos Nicolau, Witold Rużyłło, Paul W. Armstrong - Circulation 2003 cited by 320

  6. Misdiagnosis of atrial fibrillation and its clinical consequences

    Authors: Frank Bogun, Daejoon Anh, Gautham Kalahasty, Erik Wißner, Chadi Bou Serhal, Rabih Bazzi, W. Douglas Weaver, Claudio Schuger - The American Journal of Medicine 2004 cited by 167

  7. Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction

    Authors: Kerry L. Lee, Lynn H. Woodlief, Eric J. Topol, W. Douglas Weaver, Amadeo Betriu, Jacques Col, Maarten L. Simoons, Philip E. Aylward, Frans Van de Werf, Robert M. Califf - Circulation 1995 cited by 1,093

  8. Acute Coronary Care in the Elderly, Part I

    Authors: Karen P. Alexander, L. Kristin Newby, Christopher P. Cannon, Paul W. Armstrong, W. Brian Gibler, Michael W. Rich, Frans Van de Werf, Harvey D. White, W. Douglas Weaver, Mary D. Naylor, Joel M. Gore, Harlan M. Krumholz, E. Magnus Ohman - Circulation 2007 cited by 912

  9. Effects of Selective Matrix Metalloproteinase Inhibitor (PG-116800) to Prevent Ventricular Remodeling After Myocardial Infarction

    Authors: Michael Hudson, Paul W. Armstrong, Witold Rużyłło, José M. Brum, Lisa Cusmano, Piotr Krzeski, Robert A. Lyon, Miguel A. Quiñones, Pierre Théroux, Diana Sydlowski, Henry E. Kim, Mario J. García, Wael A. Jaber, W. Douglas Weaver - Journal of the American College of Cardiology 2006 cited by 210

  10. Acute Coronary Care in the Elderly, Part II

    Authors: Karen P. Alexander, L. Kristin Newby, Paul W. Armstrong, Christopher P. Cannon, W. Brian Gibler, Michael W. Rich, Frans Van de Werf, Harvey D. White, W. Douglas Weaver, Mary D. Naylor, Joel M. Gore, Harlan M. Krumholz, E. Magnus Ohman - Circulation 2007 cited by 482

  11. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention

    Authors: Philippe Gabríel Steg, Stefan James, Robert A. Harrington, Diego Ardissino, Richard C. Becker, Christopher P. Cannon, Håkan Emanuelsson, Ariel Finkelstein, Steen Husted, Hugo Katus, Jan Kilhamn, Sylvia Olofsson, Robert F. Storey, W. Douglas Weaver, Lars Wallentin, for the PLATO Study Group - Circulation 2010 cited by 504

  12. ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction:Executive Summary

    Authors: Thomas J. Ryan, Jeffrey L. Anderson, Elliott M. Antman, Blaine A. Braniff, Neil Brooks, Robert M. Califf, L. David Hillis, Loren F. Hiratzka, Elliot Rapaport, Bárbara Riegel, Richard O. Russell, Earl E. Smith, W. Douglas Weaver - Circulation 1996 cited by 305

  13. Comparison of Clinical Interpretation With Visual Assessment and Quantitative Coronary Angiography in Patients Undergoing Percutaneous Coronary Intervention in Contemporary Practice

    Authors: Brahmajee K. Nallamothu, John A. Spertus, Alexandra J. Lansky, David J. Cohen, Philip G. Jones, Faraz Kureshi, Gregory Dehmer, Joseph P. Drozda, Mary Norine Walsh, John E. Brush, Gerald Koenig, Thad F. Waites, D. Scott Gantt, George Kichura, Richard A. Chazal, Peter K. O’Brien, C. Michael Valentine, John S. Rumsfeld, Johan H. C. Reiber, Joann G. Elmore, Richard A. Krumholz, W. Douglas Weaver, Harlan M. Krumholz - Circulation 2013 cited by 152

  14. Multicenter, Randomized, Controlled Trial of 150-J Biphasic Shocks Compared With 200- to 360-J Monophasic Shocks in the Resuscitation of Out-of-Hospital Cardiac Arrest Victims

    Authors: Thomas Schneider, Patrick Martens, H.-R. Paschen, Markku Kuisma, Benno Wolcke, Bradford E. Gliner, James K. Russell, W. Douglas Weaver, Leo Bossaert, Douglas Chamberlain - Circulation 2000 cited by 331

  15. Interleukin‐18 in patients with acute coronary syndromes

    Authors: Axel Åkerblom, Stefan James, Tatevik Ghukasyan Lakic, Richard C. Becker, Christopher P. Cannon, Philippe Gabríel Steg, Anders Himmelmänn, Hugo A. Katus, Robert F. Storey, Lars Wallentin, W. Douglas Weaver, Agneta Siegbahn, on behalf of the PLATO Investigators - Clinical Cardiology 2019 cited by 31

  16. TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction

    Authors: Christopher P. Cannon, C. Michael Gibson, Carolyn H. McCabe, A.A.J. Adgey, Marc J. Schweiger, Rafael F. Sequeira, Gilles Grollier, Robert P. Giugliano, Martin J. Frey, Hiltrud S. Mueller, Richard M. Steingart, W. Douglas Weaver, Frans Van de Werf, Eugene Braunwald - Circulation 1998 cited by 356

  17. Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction

    Authors: Kenneth W. Mahaffey, Christopher B. Granger, José Carlos Nicolau, Witold Rużyłło, W. Douglas Weaver, Pierre Théroux, Judith S. Hochman, Thomas G. Filloon, Christopher F. Mojcik, Thomas G. Todaro, Paul W. Armstrong - Circulation 2003 cited by 176

  18. Use of Reperfusion Therapy for Acute Myocardial Infarction in the United States

    Authors: Hal V. Barron, Laura J. Bowlby, Tim Breen, William J. Rogers, John G. Canto, Yuan Zhang, Alan J. Tiefenbrunn, W. Douglas Weaver - Circulation 1998 cited by 318

  19. The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention

    Authors: Issam Moussa, Anthony Hermann, John C. Messenger, Gregory Dehmer, W. Douglas Weaver, John S. Rumsfeld, Frederick A. Masoudi - Heart 2013 cited by 132

  20. Factors influencing survival after out-of-hospital cardiac arrest

    Authors: W. Douglas Weaver, Leonard A. Cobb, Alfred P. Hallstrom, Carol Fahrenbruch, Michael K. Copass, Roberta M. Ray - Journal of the American College of Cardiology 1986 cited by 325

  21. Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I

    Authors: James McCord, Richard M. Nowak, Peter A. McCullough, Craig C. Foreback, Steven Borzak, Glenn Tokarski, Michael C. Tomlanovich, Gordon Jacobsen, W. Douglas Weaver - Circulation 2001 cited by 302

  22. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006

    Authors: C. Michael Gibson, Yuri B. Pride, Paul D. Frederick, Charles V. Pollack, John G. Canto, Alan J. Tiefenbrunn, W. Douglas Weaver, Costas T. Lambrew, William J. French, Eric D. Peterson, William J. Rogers - American Heart Journal 2008 cited by 280

  23. Enhanced Mortality Risk Prediction With a Focus on High-Risk Percutaneous Coronary Intervention

    Authors: James M. Brennan, Jeptha P. Curtis, David Dai, Susan Fitzgerald, Akshay Khandelwal, John A. Spertus, Sunil V. Rao, Mandeep Singh, Richard E. Shaw, Kalon K.L. Ho, Ronald J. Krone, William S. Weintraub, W. Douglas Weaver, Eric D. Peterson - JACC: Cardiovascular Interventions 2013 cited by 187

  24. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study

    Authors: Peter A. McCullough, Edward F. Philbin, John A. Spertus, Scott Kaatz, Keisha R. Sandberg, W. Douglas Weaver - Journal of the American College of Cardiology 2002 cited by 552